68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

NCT05000372 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: 68Ga-grazytracer

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]